{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:29:42Z","timestamp":1779316182266,"version":"3.51.4"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Botulinum toxin A to the glabella is a popular cosmetic intervention. Functional musculature differences may arise from chronic behavioral adjustment to high sun exposure levels, requiring greater doses. This could affect clinical practice globally. This study investigated the effect of climate on real-world doses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The authors conducted a comparative cohort study using data from a registry from a single provider practicing across two centers: the United Kingdom and Malta. They classified one center as low sun exposure (United Kingdom winter month treatment) and the other as high sun exposure (Malta summer months). Patients were followed up once every 3 weeks and received top-up doses until full clinical paralysis was achieved. To standardize the comparison, the study included only women aged 35 to 60 years undergoing glabellar botulinum toxin treatment by experienced clinicians following standard procedures from 2012 to 2019. Smokers, those not seeking maximal paralysis, those documented as not compliant with posttreatment advice, those with colds or fevers, and those with broken cold supply chains were excluded. Univariable and multivariable analyses were undertaken.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 523 patients were included: 292 \u201chigh-sun\u201d patients and 231 \u201clow-sun\u201d patients. Mean total doses were significantly higher in the high-sun group (29.2 units versus 27.3 units; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0031). When correcting for age in multivariable analysis, the low-sun group still had lower total dose requirements (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.00574).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Patients injected with glabellar botulinum toxin in high-sun climates may have significantly increased dose requirements to achieve maximal paralysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL QUESTION\/LEVEL OF EVIDENCE:<\/jats:title>\n            <jats:p>Therapeutic, III.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000010913","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T17:00:10Z","timestamp":1688662810000},"page":"57e-62e","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The Effect of Climate on the Dose Requirements of Botulinum Toxin A in Cosmetic Interventions"],"prefix":"10.1097","volume":"154","author":[{"given":"Kim L.","family":"Borsky","sequence":"first","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Stoke Mandeville Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy N.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Stoke Mandeville Hospital"},{"name":"Warwick Clinical Trials Unit, University of Warwick"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raina","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Lister Hospital"},{"name":"Aesthetic Virtue Limited (Malta); and Academy of Aesthetic Excellence."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"R1-20250501","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2165\/00128071-200304100-00005","article-title":"Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.","volume":"4","author":"Frampton","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"R2-20250501","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1111\/jocd.13702","article-title":"The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: key clinical postulates II.","volume":"19","author":"Nestor","year":"2020","journal-title":"J Cosmet Dermatol"},{"issue":"Suppl 1","key":"R3-20250501","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/asj\/sjw285","article-title":"The practical use of abobotulinumtoxinA in aesthetics.","volume":"37","author":"Kane","year":"2017","journal-title":"Aesthet Surg J"},{"key":"R4-20250501","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/CCID.S156851","article-title":"Botulinum neurotoxin formulations: overcoming the confusion.","volume":"11","author":"Samizadeh","year":"2018","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R5-20250501","first-page":"1651","article-title":"A comparison of two botulinum type a toxin preparations for the treatment of glabellar lines: double-blind, randomized, pilot study.","volume":"31","author":"Lowe","year":"2005","journal-title":"Dermatol Surg"},{"key":"R6-20250501","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2006.07.006","article-title":"Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study.","volume":"55","author":"Lowe","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R7-20250501","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.143.11.1447-b","article-title":"A randomized double-blind study of the effect of Botox and Dysport\/Reloxin on forehead wrinkles and electromyographic activity.","volume":"143","author":"Karsai","year":"2007","journal-title":"Arch Dermatol"},{"key":"R8-20250501","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1090820X11430685","article-title":"Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles.","volume":"32","author":"Michaels","year":"2012","journal-title":"Aesthet Surg J"},{"key":"R9-20250501","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/DSS.0000000000001277","article-title":"Botulinum toxin in aesthetic medicine: myths and realities.","volume":"44","author":"Dover","year":"2018","journal-title":"Dermatol Surg"},{"key":"R10-20250501","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.det.2013.09.009","article-title":"Aesthetic uses of the botulinum toxin.","volume":"32","author":"Dorizas","year":"2014","journal-title":"Dermatol Clin"},{"key":"R11-20250501","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/DSS.0000000000000291","article-title":"Effect of a second injection of botulinum toxin on lower facial contouring, as evaluated using 3-dimensional laser scanning.","volume":"41","author":"Lee","year":"2015","journal-title":"Dermatol Surg"},{"key":"R12-20250501","first-page":"1434","article-title":"Botulinum toxin in men: review of relevant anatomy and clinical trial data.","volume":"39","author":"Keaney","year":"2013","journal-title":"Dermatol Surg"},{"key":"R13-20250501","first-page":"1041","article-title":"Consideration of muscle mass in glabellar line treatment with botulinum toxin type A.","volume":"11","author":"Monheit","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"R14-20250501","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/CCID.S41537","article-title":"Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study.","volume":"6","author":"Rappl","year":"2013","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R15-20250501","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1524-4725.2011.02075.x","article-title":"Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A.","volume":"37","author":"Schlessinger","year":"2011","journal-title":"Dermatol Surg"},{"key":"R16-20250501","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/PRS.0b013e3181b5641b","article-title":"Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study.","volume":"124","author":"Kane","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"R17-20250501","first-page":"439","article-title":"The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.","volume":"8","author":"Rubin","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"R18-20250501","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/ciia.2007.2.1.81","article-title":"Cosmetic use of botulinum toxin type A in the elderly.","volume":"2","author":"Cheng","year":"2007","journal-title":"Clin Interv Aging"},{"key":"R19-20250501","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/2231-0762.161227","article-title":"Botulinum toxin for the treatment of hyperfunctional lines of the forehead.","volume":"5","author":"Sunil","year":"2015","journal-title":"J Int Soc Prev Community Dent"},{"key":"R20-20250501","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1524-4725.2012.02551.x","article-title":"AbobotulinumtoxinA for reduction of glabellar lines in patients with skin of color: post hoc analysis of pooled clinical trial data.","volume":"38","author":"Taylor","year":"2012","journal-title":"Dermatol Surg"},{"key":"R21-20250501","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/dsu.12317","article-title":"Consensus recommendations on the aesthetic usage of botulinum toxin type A in Asians.","volume":"39","author":"Ahn","year":"2013","journal-title":"Dermatol Surg"},{"key":"R22-20250501","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1085-5629(96)80003-4","article-title":"Aesthetic and anatomic analysis of the aging skin.","volume":"15","author":"Glogau","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"R23-20250501","article-title":"Defining research table."},{"key":"R24-20250501","article-title":"Highlights of prescribing information."},{"issue":"Suppl 1","key":"R25-20250501","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/asj\/sjw282","article-title":"Key parameters for the use of abobotulinumtoxinA in aesthetics: onset and duration.","volume":"37","author":"Nestor","year":"2017","journal-title":"Aesthet Surg J"},{"key":"R26-20250501","first-page":"A160","article-title":"Benefits of sunlight: a bright spot for human health.","volume":"116","author":"Mead","year":"2008","journal-title":"Environ Health Perspect"},{"key":"R27-20250501","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/derm.24054","article-title":"Vitamin D status and sun exposure in Southeast Asia.","volume":"5","author":"Nimitphong","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"R28-20250501","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/DSS.0000000000001045","article-title":"Different glabellar contraction patterns in Chinese and efficacy of botulinum toxin type A for treating glabellar lines: a pilot study.","volume":"43","author":"Jiang","year":"2017","journal-title":"Dermatol Surg"},{"key":"R29-20250501","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1524-4725.2012.02505.x","article-title":"Glabellar contraction patterns: a tool to optimize botulinum toxin treatment.","volume":"38","author":"de Almeida","year":"2012","journal-title":"Dermatol Surg"},{"issue":"Suppl 1","key":"R30-20250501","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/DSS.0000000000000162","article-title":"Prolonging the duration of masseter muscle reduction by adjusting the masticatory movements after the treatment of masseter muscle hypertrophy with botulinum toxin type a injection.","volume":"41","author":"Wei","year":"2015","journal-title":"Dermatol Surg"},{"key":"R31-20250501","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.toxicon.2010.12.019","article-title":"Studies on the dissociation of botulinum neurotoxin type A complexes.","volume":"57","author":"Eisele","year":"2011","journal-title":"Toxicon"},{"key":"R32-20250501","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archdermatol.2009.128","article-title":"Increasing the field effects of similar doses of Clostridium botulinum type A toxin-hemagglutinin complex in the treatment of compensatory hyperhidrosis.","volume":"145","author":"Hexsel","year":"2009","journal-title":"Arch Dermatol"},{"key":"R33-20250501","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/23328940.2019.1632145","article-title":"Physiology of sweat gland function: the roles of sweating and sweat composition in human health.","volume":"6","author":"Baker","year":"2019","journal-title":"Temperature (Austin)"},{"key":"R34-20250501","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbrc.2012.11.048","article-title":"Time course and temperature dependence of the membrane translocation of tetanus and botulinum neurotoxins C and D in neurons.","volume":"430","author":"Pirazzini","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"R35-20250501","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3565(25)31908-7","article-title":"Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction.","volume":"212","author":"Simpson","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"issue":"1 Spec No","key":"R36-20250501","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1111\/j.1524-4725.2006.32338.x","article-title":"UV-B irradiation attenuates dermal effects of botulinum toxin A: a randomized, double-blind, placebo-controlled study.","volume":"33","author":"Sycha","year":"2007","journal-title":"Dermatol Surg"},{"key":"R37-20250501","article-title":"Population: demographic situation, languages and religions."},{"key":"R38-20250501","article-title":"Regional ethnic diversity."},{"key":"R39-20250501","article-title":"Is R-squared useless?"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000010913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:03:39Z","timestamp":1746144219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000010913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000010913","relation":{},"ISSN":["0032-1052","1529-4242"],"issn-type":[{"value":"0032-1052","type":"print"},{"value":"1529-4242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]}}}